| Oritsejolomi Roberts, MD | |
|
200 Henry Clay Ave, New Orleans, LA 70118-5720 | |
| (504) 899-9511 | |
| Not Available |
| Full Name | Oritsejolomi Roberts |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 200 Henry Clay Ave, New Orleans, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972659506 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 206486 (Louisiana) | Primary |
| Entity Name | Louisiana State University School Of Med In New Orleans Faculty Grou |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932492626 PECOS PAC ID: 9739358722 Enrollment ID: O20110810000538 |
News Archive
The governor of Massachusetts wants to hire private insurers or other third parties to manage care for the poor and chronically ill patients who use a disproportionate share of public health-care dollars. The proposal comes as state and federal officials search for a cheaper way to deliver health care to people known as "dual eligibles." These are the 9.2 million in the U.S. who receive both Medicare, the federal program for those 65 and older or disabled, and Medicaid, the joint state-federal health plan for the poor.
Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in the prevention of recurrent ischemic stroke in patients who previously had a cryptogenic stroke.
Squamous cell carcinoma is the second-most-common form of skin cancer. Evidence suggests the human papilloma virus plays a role in the development of some types of this skin cancer.
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, today announced preliminary unaudited financial results for the full year ended December 31, 2009.
EndoSphere Inc., a medical technology company that holds 23 U.S. and international issued and pending patents, announced today that the U.S. Patent and Trademark Office has issued the company a patent covering the use of its endoscopically implantable devices for the treatment of metabolic diseases, including obesity and type 2 diabetes.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Oritsejolomi Roberts, MD 200 Henry Clay Ave, New Orleans, LA 70118-5720 Ph: (504) 899-9511 | Oritsejolomi Roberts, MD 200 Henry Clay Ave, New Orleans, LA 70118-5720 Ph: (504) 899-9511 |
News Archive
The governor of Massachusetts wants to hire private insurers or other third parties to manage care for the poor and chronically ill patients who use a disproportionate share of public health-care dollars. The proposal comes as state and federal officials search for a cheaper way to deliver health care to people known as "dual eligibles." These are the 9.2 million in the U.S. who receive both Medicare, the federal program for those 65 and older or disabled, and Medicaid, the joint state-federal health plan for the poor.
Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in the prevention of recurrent ischemic stroke in patients who previously had a cryptogenic stroke.
Squamous cell carcinoma is the second-most-common form of skin cancer. Evidence suggests the human papilloma virus plays a role in the development of some types of this skin cancer.
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, today announced preliminary unaudited financial results for the full year ended December 31, 2009.
EndoSphere Inc., a medical technology company that holds 23 U.S. and international issued and pending patents, announced today that the U.S. Patent and Trademark Office has issued the company a patent covering the use of its endoscopically implantable devices for the treatment of metabolic diseases, including obesity and type 2 diabetes.
› Verified 4 days ago
Robert L Applebaum, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3434 Prytania St., Suite 230, New Orleans, LA 70115 Phone: 504-340-6976 Fax: 504-349-6786 | |
Pervez Ahmad Khan, MBBS Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave Fl 5, New Orleans, LA 70112 Phone: 504-988-5561 Fax: 504-988-1731 | |
Derrick Umansky, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 131 S Robertson St, #8047, New Orleans, LA 70112 Phone: 504-988-5565 | |
Dr. Aaron S. Dumont, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 131 S Robertson St, Suite 1300, New Orleans, LA 70112 Phone: 504-988-5565 Fax: 504-988-5793 | |
Dr. Olawale A. R. Sulaiman, MD, PHD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1514 Jefferson Highway, New Orleans, LA 70121 Phone: 504-842-4000 | |
Arthur Wang, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave # 8047, New Orleans, LA 70112 Phone: 504-988-3524 | |
Dr. Bradley Joseph Bartholomew, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3629 Prytania St, New Orleans, LA 70115 Phone: 504-895-9544 Fax: 504-895-9548 |